New drugs for non‐alcoholic steatohepatitis-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

New drugs for non‐alcoholic steatohepatitis

Published:2020-02 Issue:S1 Volume:40 Page:96-101
ISSN:1478-3223
Container-title:Liver International
language:en
Short-container-title:Liver Int

Author:

Cardoso Ana‐Carolina¹²^ORCID,Figueiredo‐Mendes Claudio³^ORCID,A. Villela‐Nogueira Cristiane¹²^ORCID,Sanyal Arun J.⁴^ORCID

Affiliation:

1. Hepatology Division Clementino Fraga Filho University Hospital Rio de Janeiro Brazil

2. School of Medicine Federal University of Rio de Janeiro Rio de Janeiro Brazil

3. Hepatology Division General Hospital of Santa Casa do Rio de Janeiro Rio de Janeiro Brazil

4. Division of Gastroenterology Hepatology and Nutrition Virginia Commonwealth University School of Medicine Richmond VA USA

Funder

Conselho Nacional de Desenvolvimento Científico e Tecnológico

Fundação Carlos Chagas Filho de Amparo à Pesquisa do Estado do Rio de Janeiro

National Institutes of Health

Publisher

Wiley

Subject

Hepatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/liv.14354

Reference20 articles.

1. Bile Acid Derivatives as Ligands of the Farnesoid X Receptor. Synthesis, Evaluation, and Structure−Activity Relationship of a Series of Body and Side Chain Modified Analogues of Chenodeoxycholic Acid

2. New developments in the treatment of primary biliary cholangitis – role of obeticholic acid

3. Farnesoid X nuclear receptor ligand obeticholic acid for non-cirrhotic, non-alcoholic steatohepatitis (FLINT): a multicentre, randomised, placebo-controlled trial

4. REGENERATE: Design of a pivotal, randomised, phase 3 study evaluating the safety and efficacy of obeticholic acid in patients with fibrosis due to nonalcoholic steatohepatitis

5. Obeticholic acid for the treatment of non-alcoholic steatohepatitis: interim analysis from a multicentre, randomised, placebo-controlled phase 3 trial

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Nanoformulations for the diagnosis and treatment of metabolic dysfunction-associated steatohepatitis;Acta Biomaterialia;2024-08

2. Effect of Herbal Medicine on Insulin Signaling Pathways and Insulin Resistance in Metabolic Dysfunction-associated Fatty Liver Disease: A Review;The Natural Products Journal;2024-06-04

3. CD47, a novel YAP target gene, contributes to hepatic stellate cell activation and liver fibrosis induced by high-fat diet;Heliyon;2024-05

4. Understanding the Burden of Nonalcoholic Fatty Liver Disease: Time for Action;Diabetes Spectrum;2024-02-01

5. Cholesterol-associated LocusEHBP1Protects against NASH Fibrosis;2023-07-10

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3